Telomere length and hTERT genetic variants as potential prognostic markers in multiple myeloma

  • Gerecke, C. et al. The diagnosis and treatment of multiple myeloma. Dtsch. Arztebl. Int. 113, 470–476 (2016).

    PubMed 
    PubMed Central 

    Google Scholar 

  • Naymagon, L. & Abdul-Hay, M. Novel agents in the treatment of multiple myeloma: A review about the future. J. Hematol. Oncol. 9, 52 (2016).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Aksenova, A. Y. et al. Genome instability in multiple myeloma: Facts and factors. Cancers 13, 5949 (2021).

    Article 
    CAS 
    PubMed 
    PubMed…

  • Continue Reading


    News Source: www.nature.com


    Posted

    in

    by

    Tags: